You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TBPH Award Disclosure
O'connor Donal · SEC Form 4 · Filed Jun 16, 2026
Award
Calculated transaction value
$0
O'connor Donal Director
TBPH
Theravance Biopharma
TBPH
Transaction date
Jun 12, 2026
Public filing date
Jun 16, 2026
Filing lag
Filed 4 days later
TBPH daily price context
Close on/before transaction
$16.64
Jun 12, 2026
First close after public filing
$16.71
Jun 17, 2026
30-day return after filing
+1.56%
Through Jul 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 6,009 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001625377-26-000004
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Theravance Biopharma, Inc. TBPH Current | Award | Jun 12, 2026 | $0 |
| Theravance Biopharma, Inc. TBPH | Award | Jun 12, 2026 | $0 |